These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5835260)

  • 21. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
    Sloots A; Mastini C; Rohrbach F; Weth R; Curcio C; Burkhardt U; Jäger E; Forni G; Cavallo F; Wels WS
    Clin Cancer Res; 2008 Nov; 14(21):6933-43. PubMed ID: 18980988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigens on naturally occurring animal and human tumors detected by monoclonal antibodies.
    Embleton MJ; Gunn B; Byers VS; Baldwin RW
    Transplant Proc; 1981 Dec; 13(4):1966-9. PubMed ID: 6949387
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of antibodies on L5178Y mouse leukemia cells cultured in vitro.
    Yang TJ; Vas SI
    Cancer Res; 1970 May; 30(5):1231-5. PubMed ID: 5426928
    [No Abstract]   [Full Text] [Related]  

  • 24. Targeting her-2/neu with antirat Neu virosomes for cancer therapy.
    Waelti E; Wegmann N; Schwaninger R; Wetterwald A; Wingenfeld C; Rothen-Rutishauser B; Gimmi CD
    Cancer Res; 2002 Jan; 62(2):437-44. PubMed ID: 11809693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune alterations related to age, sex, and mammary tumor detection in murine mammary tumor virus-infected mice.
    Benoist H; Dufer J; Bouchet C; Desplaces A
    J Natl Cancer Inst; 1982 Dec; 69(6):1208. PubMed ID: 6958900
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell interactions in leukemia-associated immunosuppression: suppression of thymus-independent antibody responses by leukemia spleen cells (Moloney) in vitro is mediated by normal T cells.
    Caulfield MJ; Cerny J
    J Immunol; 1980 Jan; 124(1):255-60. PubMed ID: 6965291
    [No Abstract]   [Full Text] [Related]  

  • 27. Autochthonous humoral immune responses to exogenous and endogenous murine mammary tumor viruses in C3H (Jax) and ICRC mice.
    Chiplunkar SV; Gangal SG; Karande KA
    Indian J Exp Biol; 1984 Dec; 22(12):662-5. PubMed ID: 6100106
    [No Abstract]   [Full Text] [Related]  

  • 28. [Oncogenes and target cells in the mechanism of leukemogenesis].
    Butenko ZA
    Vopr Onkol; 1983; 29(7):101-9. PubMed ID: 6349119
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9.
    Aurisicchio L; Peruzzi D; Conforti A; Dharmapuri S; Biondo A; Giampaoli S; Fridman A; Bagchi A; Winkelmann CT; Gibson R; Kandimalla ER; Agrawal S; Ciliberto G; La Monica N
    Clin Cancer Res; 2009 Mar; 15(5):1575-84. PubMed ID: 19240169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aging and cancerigenesis. 3. Effect of age on isoantibody formation.
    Aoki T; Teller MN
    Cancer Res; 1966 Aug; 26(8):1648-52. PubMed ID: 5923163
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of treatment with L-phenylalanine mustard and L-phenylalanine mustard antibody on the survival time of mice with intracerebral ependymoblastomas.
    Papadakis N; Burke JF; Mark VH
    J Surg Oncol; 1973 May; 5(5):517-22. PubMed ID: 4752469
    [No Abstract]   [Full Text] [Related]  

  • 32. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA; Gladu J
    Cancer Res; 2002 Apr; 62(8):2390-7. PubMed ID: 11956102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
    Weiss A; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of immunologic hyperstimulation on murine viral leukemogenesis.
    Siegel BV; Morton JI
    Blood; 1967 Apr; 29(4):Suppl:585-93. PubMed ID: 6022295
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoclonal anti-MM46 antibody:ricin A chain conjugate: in vitro and in vivo antitumor activity.
    Seto M; Umemoto N; Saito M; Masuho Y; Hara T; Takahashi T
    Cancer Res; 1982 Dec; 42(12):5209-15. PubMed ID: 6814753
    [No Abstract]   [Full Text] [Related]  

  • 37. Significance of the co-existance of Friend virus in "Friend tumour".
    Kobayashi H; Kodama T; Itoh T
    Nature; 1966 Nov; 212(5065):939-40. PubMed ID: 6003736
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice.
    Sakai Y; Morrison BJ; Burke JD; Park JM; Terabe M; Janik JE; Forni G; Berzofsky JA; Morris JC
    Cancer Res; 2004 Nov; 64(21):8022-8. PubMed ID: 15520211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A DNA vaccine against acute promyelocytic leukemia in the mouse.
    Rosti V
    Haematologica; 2005 Aug; 90(8):1010B. PubMed ID: 16079090
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhanced cytostatic effectiveness of aniline mustard against 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors during regression in response to ovariectomy.
    Benckhuysen C; Ter Hart HG; Van Dijk PJ
    Cancer Treat Rep; 1981; 65(7-8):567-74. PubMed ID: 6788369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.